Strong patient interest in the only federally approved CBD product in the United States helped drugmaker GW Pharmaceuticals record $72 million in revenue last quarter. Epidiolex, a seizure control drug approved by the U.S. Food and Drug Administration, has seen brisk sales and new patient enrollments since the drug’s launch last November. GW Pharma (Nasdaq: GWPH) reported that […]
Strong CBD drug release powers GW Pharmaceuticals’ record revenue is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs
source https://hempgenixs.com/2019/08/07/strong-cbd-drug-release-powers-gw-pharmaceuticals-record-revenue/?utm_source=rss&utm_medium=rss&utm_campaign=strong-cbd-drug-release-powers-gw-pharmaceuticals-record-revenue
No comments:
Post a Comment